22Jun 2019

MALIGNANT MIXED MULLERIAN TUMOR (UTERINE CARCINOSARCOMA) PRESENTED AS FIBROID UTERUS - A CASE REPORT.

  • Senior Demonstrator, Department of pathology.
  • Assistant Professor, Department of Pathology.
  • Associate Professor, Department of Pathology.
  • Dr. Sampurnanand Medical College Jodhpur (Raj).
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Malignant mixed mullerian tumor of the uterus, also called carcinosarcoma, is a very rare and aggressive type of malignancy with epithelial and mesenchymal component. It can occur anywhere along the female genital tract, like uterus, ovary, fallopian tube, cervix. Uterus is the commonest site, representing less than 5% of uterine malignancy. Here we presenting a case of 65 yr old postmenopausal women admitted to hospital with complain of vaginal discharge from 2 month duration. Hysterectomy with bilateral salpingo-oopherectomy remain the mainstay of treatment , high rate of recurrence and metastasis suggest a need for lymphadenectomy and post operative adjuvant treatment.


  1. A. El-Nashar and A. Mariani, ―Uterine carcinosarcoma,‖ Clinical Obstetrics and Gynecology, vol. 54, 2, pp. 292?304, 2011.
  2. Ahuja, R. Safaya, G. Prakash, L. Kumar, and N. K. Shukla, ―Primary mixed mullerian tumor of the vagina?a case report with review of the literature,‖ Pathology Research and Practice, vol. 207, no. 4, pp. 253?255, 2011.
  3. K. Sharma, J. I. Sorosky, D. Bender, M. S. Fletcher, and A. K. Sood, ― Malignant mixed mullerian tumor (MMMT) of the cervix,‖ Gynecologic Oncology, vol. 97, no. 2, pp. 442?445, 2005.
  4. A. de Jong, H. W. Nijman, T. F. Wijbrandi, A. K. Reyners, H. M. Boezen, and H. Hollema, ?Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component,??Modern Pathology.
  5. Arora, S. Rao, N. Khurana, D. Talwar, and R. Tanwar, ?Malignant mixed Mullerian tumor of broad ligament with synchronous ovarian and endometrial carcinoma: a rare association,??Journal of Cancer Research and Therapeutics, vol. 7, no. 1, pp. 88?91, 2011.
  6. S. Bosquet, S. A. Terstriep, W. A. Cliby et al., ―The impact of multi-modal therapy on survival for uterine carcinosarcomas,‖ Gynecologic Oncology, vol. 116, no. 3, pp. 419?423, 2010.
  7. Brooks SE, Zhan M, Cote T, et al. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989?1999. Gynecol Oncol. 2004;93:204?208.
  8. Afonso JF. Mixed mesodermal tumors of the uterus.?West J Med.?1974;120(1):17?26.
  9. George E, Manivel JC, Dehner LP, et al. Malignant mixed Mullerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 1991;22:215?23.
 

[Laxmi Aheer, Taruna chaudhary, Yogi Raj Joshi and Shilpa Agrawal. (2019); MALIGNANT MIXED MULLERIAN TUMOR (UTERINE CARCINOSARCOMA) PRESENTED AS FIBROID UTERUS - A CASE REPORT. Int. J. of Adv. Res. 7 (Jun). 990-993] (ISSN 2320-5407). www.journalijar.com


Dr Yogi raj Joshi
Associate Professor Dr S N Medical College Jodhpur

DOI:


Article DOI: 10.21474/IJAR01/9302      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9302